Starsource Multitrade (506365) Q4 04/05 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 04/05 earnings summary
21 Oct, 2026Executive summary
FY ended 31 Mar 2005 net loss widened to Rs.4,380,554 from Rs.693,715; manufacturing remained shut throughout the year amid obsolete plant and machinery.
Management said manufacturing was unviable and was exploring sale, lease or disposal options to restore viability, subject to shareholder approval.
Financial highlights
Total income was Rs.1,140, entirely reported as dividend income; total expenditure was Rs.4,061,252, including Rs.3,082,202 for employee remuneration and benefits.
Depreciation was Rs.320,442; loss before and after tax was Rs.4,380,554, versus Rs.693,715 in FY 2003-04.
Accumulated loss carried to the balance sheet reached Rs.29,871,151, up from Rs.25,490,597; shareholders’ funds remained Rs.66,414,738.
Investments declined to Rs.34,009,061 from Rs.39,156,541; unsecured loans fell to Rs.2,116,976 from Rs.9,052,211.
Outlook and guidance
No operating forecast was stated; management was evaluating projects that could involve sale, lease or disposal of all or part of the undertaking, with shareholder approval to be sought.
Latest events from Starsource Multitrade
- Tax write-back lifted net profit as factory operations restarted and Fine Chemicals trials advanced.506365
Q4 96/97 - A continuing factory lockout and Rs. 83,23,334 pre-tax loss defined the year.506365
Q4 97/98 - Continued lockout, Rs.4.488m net loss, and major unprovided liabilities and investment impairment.506365
Q4 98/99 - Lockout halted operations; FY2002-03 net loss was Rs.863,221 as leasing talks continued.506365
Q4 02/03 - Manufacturing ceased after asset sales; diversification and material financial risks remain.506365
Q4 06/07 - Manufacturing stayed halted; FY08 PAT fell to Rs 0.08 lakh as diversification remained uncertain.506365
Q4 07/08 - Suspended manufacturing, falling income and auditor-flagged asset and loan risks defined FY10.506365
Q4 09/10 - A modest return to profit amid suspended operations, material audit concerns, and suspended share trading.506365
Q4 10/11 - Investment-sale income drove FY12 profit as manufacturing remained suspended.506365
Q4 11/12